...
首页> 外文期刊>Orphanet journal of rare diseases >Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy
【24h】

Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy

机译:意大利儿童神经元类固醇脂质体融合病的分子流行病学

获取原文
           

摘要

Background To review the descriptive epidemiological data on neuronal ceroid lipofuscinoses (NCLs) in Italy, identify the spectrum of mutations in the causative genes, and analyze possible genotype-phenotype relations. Methods A cohort of NCL patients was recruited through CLNet, a nationwide network of child neurology units. Diagnosis was based on clinical and pathological criteria following ultrastructural investigation of peripheral tissues. Molecular confirmation was obtained during the diagnostic procedure or, when possible, retrospectively. Results One hundred eighty-three NCL patients from 156 families were recruited between 1966 and 2010; 124 of these patients (from 88 families) were tested for known NCL genes, with 9.7% of the patients in this sample having not a genetic diagnosis. Late infantile onset NCL (LINCL) accounted for 75.8% of molecularly confirmed cases, the most frequent form being secondary to mutations in CLN2 (23.5%). Juvenile onset NCL patients accounted for 17.7% of this cohort, a smaller proportion than found in other European countries. Gene mutations predicted severe protein alterations in 65.5% of the CLN2 and 78.6% of the CLN7 cases. An incidence rate of 0.98/100,000 live births was found in 69 NCL patients born between 1992 and 2004, predicting 5 new cases a year. Prevalence was 1.2/1,000,000. Conclusions Descriptive epidemiology data indicate a lower incidence of NCLs in Italy as compared to other European countries. A relatively high number of private mutations affecting all NCL genes might explain the genetic heterogeneity. Specific gene mutations were associated with severe clinical courses in selected NCL forms only.
机译:背景要回顾意大利关于神经元类固醇脂褐藻糖(NCL)的描述性流行病学数据,鉴定致病基因突变的频谱,并分析可能的基因型与表型的关系。方法通过全国儿童神经病学网络CLNet招募一组NCL患者。诊断基于周围组织的超微结构检查后的临床和病理学标准。在诊断过程中,或在可能的情况下,回顾性获得分子确认。结果1966年至2010年间,共纳入156个家庭的183例NCL患者。测试了这些患者中的124个(来自88个家庭)的已知NCL基因,其中该样本中有9.7%的患者没有遗传诊断。晚期婴儿发作的NCL(LINCL)占分子确诊病例的75.8%,最常见的形式是继发于CLN2的突变(23.5%)。少年性NCL患者占这一队列的17.7%,比其他欧洲国家小。基因突变预测在65.5%的CLN2和78.6%的CLN7病例中存在严重的蛋白质改变。在1992年至2004年之间出生的69名NCL患者中,发现活产的发生率为0.98 / 100,000例,预计每年有5例新病例。患病率为1.2 / 1,000,000。结论描述性流行病学数据表明,与其他欧洲国家相比,意大利的NCL发生率较低。影响所有NCL基因的相对大量的私人突变可能解释了遗传异质性。特定基因突变仅与特定NCL形式的严重临床过程相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号